Form 4 for ONC BeOne Medicines Ltd.
Accepted 2025-11-13 00:00:00 ET · period of report 2025-11-11 · accession 0001042047-25-000007 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-11-13 | 2025-11-11+ | ONC | OYLER JOHN | CEO, Dir | G - Gift | $0.00 | -1.01M | 7.30M | -12% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2025-11-12 | G | D | 858,533 | $0.00 | 6,441,041 | D | — | — | (F1) Bona fide gift of shares to a private foundation which is exempt from Section 16(b) of the Securities Exchange Act pursuant to Rule 16b-5. |
| 2 | Common | Ordinary Shares | 2025-11-11 | G | D | 151,320 | $0.00 | 7,299,574 | D | — | — | (F1) Bona fide gift of shares to a private foundation which is exempt from Section 16(b) of the Securities Exchange Act pursuant to Rule 16b-5. |